Agilent Prices Public Offering of Senior Notes at $400M | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday.

The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

The Santa Clara, Calif.-based company announced the offering earlier on Monday but did not price it. Following the announcement, ratings agencies Moody's and Fitch issued ratings on the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.